Risperidone in Combination With Other Drugs: Experimental Research in Individuals With Autism Spectrum Disorder

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Experimental and clinical psychopharmacology

• Publication date

  2017-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1037/pha0000144PMID 29048191
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Board Certified Behavior Analysts and Psychotropic Medications: Slipshod Training, Inconsistent Involvement, and Reason for Hope

  2018cited by this paper
• N-Acetylcysteine as an Adjunctive Therapy to Risperidone for Treatment of Irritability in Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Efficacy and Safety

  2015cited by this paper
• A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism.

  2015cited by this paper
• Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: A chart review study

  2015cited by this paper
• A randomized double-blind placebo-controlled clinical trial of adjuvant buspirone for irritability in autism.

  2015cited by this paper
• Factor validity and reliability of the aberrant behavior checklist-community (ABC-C) in an Indian population with intellectual disability.

  2015cited by this paper
• Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program

  2014cited by this paper
• Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial

  2014cited by this paper
• Double-Blind, Placebo-Controlled Trial of Risperidone Plus Amantadine in Children With Autism: A 10-Week Randomized Study

  2013cited by this paper
• Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care

  2013cited by this paper
• Riluzole as an Adjunctive Therapy to Risperidone for the Treatment of Irritability in Children with Autistic Disorder: A Double-Blind, Placebo-Controlled, Randomized Trial

  2013cited by this paper
• Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

  2013cited by this paper
• A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders

  2013cited by this paper
• Psychotropic Medication Use and Polypharmacy in Children With Autism Spectrum Disorders

  2013cited by this paper
• Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial

  2012cited by this paper
• Psychotropic Medications in Children with Autism Spectrum Disorders: A Systematic Review and Synthesis for Evidence-Based Practice

  2012cited by this paper
• Psychotropic Medication Use in Children With Autism in the Kentucky Medicaid Population

  2012cited by this paper
• Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.

  2010cited by this paper
• Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.

  2010cited by this paper
• A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.

  2009cited by this paper
• Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder

  2009cited by this paper
• Psychotropic Medication Use Among Medicaid-Enrolled Children With Autism Spectrum Disorders

  2008cited by this paper
• Buspirone for Autistic Disorder in a Woman with an Intellectual Disability

  2008cited by this paper
• Progress in evidence-based medicine.

  2008cited by this paper
• A Double-blind Placebo Controlled Trial of Piracetam Added to Risperidone in Patients with Autistic Disorder

  2008cited by this paper
• Effect of pioglitazone treatment on behavioral symptoms in autistic children

  2007cited by this paper
• AProspective, Open-Label Trial of Galantamine in Autistic Disorder

  2006cited by this paper
• Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.

  2005cited by this paper
• Epidemiological Surveys of Autism and Other Pervasive Developmental Disorders: An Update

  2003cited by this paper
• Risperidone in children with autism and serious behavioral problems.

  2002cited by this paper
• Drug synergism: its detection and applications.

  2001cited by this paper
• The double-blind, randomized, placebo-controlled trial: gold standard or golden calf?

  2001cited by this paper
• Factor validity and reliability for the Aberrant Behavior Checklist-Community in a Japanese population with mental retardation.

  1996cited by this paper
• Rating problem behaviors in outpatients with mental retardation: use of the Aberrant Behavior Checklist.

  1991cited by this paper
• The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

  1985cited by this paper

• Risperidone and aripiprazole for autism spectrum disorder in children: an overview of systematic reviews

  2022cites this paper
• A Systematic Review of Direct Assessments to Evaluate Psychotropic Medication Effects for Children With Disabilities.

  2022cites this paper
• Psychotropic Polypharmacy Among Children and Youth with Autism: A Systematic Review

  2021influential citation
• Increased Dopamine Type 2 Gene Expression in the Dorsal Striatum in Individuals With Autism Spectrum Disorder Suggests Alterations in Indirect Pathway Signaling and Circuitry

  2020cites this paper
• Board Certified Behavior Analysts and Psychotropic Medications: Slipshod Training, Inconsistent Involvement, and Reason for Hope

  2018cites this paper
• Psychotropic Medications as Treatments for People with Autism Spectrum Disorder

  2017cites this paper